Cita APA

Zarei, M., Pujol, E., Quesada‐López, T., Villarroya, F., Barroso, E., Vázquez, S., . . . Vázquez‐Carrera, M. (2019). Oral administration of a new HRI activator as a new strategy to improve high‐fat‐diet‐induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21. Br J Pharmacol.

Chicago Style Citation

Zarei, Mohammad, Eugènia Pujol, Tania Quesada‐López, Francesc Villarroya, Emma Barroso, Santiago Vázquez, Javier Pizarro‐Delgado, Xavier Palomer, i Manuel Vázquez‐Carrera. "Oral Administration of a New HRI Activator As a New Strategy to Improve High‐fat‐diet‐induced Glucose Intolerance, Hepatic Steatosis, and Hypertriglyceridaemia Through FGF21." Br J Pharmacol 2019.

Cita MLA

Zarei, Mohammad, et al. "Oral Administration of a New HRI Activator As a New Strategy to Improve High‐fat‐diet‐induced Glucose Intolerance, Hepatic Steatosis, and Hypertriglyceridaemia Through FGF21." Br J Pharmacol 2019.